Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
27.7%
% of IDNA's 51 holdings also in BBP
25.0%
% of BBP's 55 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
SPRINGWORKS THERAPEUTICS, INC. | 2.6% | 2.6% | 2.6% |
|
SAREPTA THERAPEUTICS INC | 5.3% | 2.4% | 2.4% |
|
REGENERON PHARMACEUTICALS | 4.3% | 2.0% | 2.0% |
|
MODERNA, INC. | 5.0% | 2.0% | 2.0% |
|
EXELIXIS INC | 4.0% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to BBP
|
REVOLUTION MEDICINES, INC. | 5.6% |
|
MERCK & CO. INC. | 4.7% |
 |
SANOFI-AVENTIS | 3.9% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 3.6% |
 |
GENMAB A/S | 3.6% |
 |
ROCHE HOLDING LTD | 3.5% |
 |
BEIGENE, LTD. | 3.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 3.0% |
|
MODERNA, INC. | 3.0% |
|
SAREPTA THERAPEUTICS INC | 2.9% |
IDNA Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
APELLIS PHARMACEUTICALS, INC. | -2.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | -2.1% |
|
PTC THERAPEUTICS INC | -2.1% |